HIND
Vyome Holdings, Inc.NASDAQHealthcare$2.13+1.65%ClosedMarket Cap: $12.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.24
P/S
5.01
EV/EBITDA
-2.64
DCF Value
$1.84
FCF Yield
-66.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
54.3%
Operating Margin
-584.0%
Net Margin
-452.4%
ROE
-365.0%
ROA
-168.9%
ROIC
-373.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $36.6K | 53.0% | $-1.4M | $-1.2M | $-0.21 | — |
| FY 2025 | $319.7K | 64.7% | $-2.7M | $-10.3M | $-4.75 | — |
| Q3 2025 | $34.6K | 52.1% | $-8.6M | $-8.6M | $-29.42 | — |
| Q2 2025 | $1.2M | 48.2% | $-2.1M | $-2.6M | $-9.00 | — |
| Q1 2025 | $1.1M | 61.2% | $-2.2M | $1.5M | $9.42 | — |
| Q4 2024 | $1.8M | 73.1% | $-1.7M | $-1.8M | $-60.31 | — |
| FY 2024 | $8.0M | 63.2% | $-7.7M | $-7.1M | $-345.74 | — |
| Q3 2024 | $2.3M | 62.8% | $-1.8M | $-1.6M | $-77.67 | — |
| Q2 2024 | $2.0M | 57.7% | $-2.1M | $-1.6M | $-91.70 | — |
| Q1 2024 | $1.9M | 59.9% | $-2.2M | $-2.2M | $-135.56 | — |
| Q4 2023 | $2.0M | 92.9% | $-1.9M | $-1.7M | $-104.97 | — |
| FY 2023 | $8.7M | 63.9% | $-14.6M | $-11.4M | $-2,771.94 | — |